A practical procedure for the large-scale preparation of methyl (2R,3S)-3-(4-methoxyphenyl)glycidate, a key intermediate for diltiazem.
Toshiyuki Furutani, Ritsuo Imashiro, Masanori Hatsuda, Masahiko Seki
Index: J. Org. Chem. 67(13) , 4599-601, (2002)
Full Text: HTML
Abstract
A practical synthesis of methyl (2R,3S)-3-(4-methoxyphenyl)glycidate (-)-2, a key intermediate for diltiazem (1), was developed. Treatment of methyl (E)-4-methoxycinnamate 3 with chiral dioxirane, generated from chiral ketone 4, provided (-)-2 in 77% ee and 89% yield. The crude mixture of (-)-2 and 4 was efficiently separated by the use of novel and simple equipment performing a lipase-catalyzed transesterification and a continuous dissolution and crystallization to furnish the optically pure (-)-2 and recovery of 4 in 74% and 91% yield, respectively.
Related Compounds
Related Articles:
2004-12-01
[J. Ind. Microbiol. Biotechnol. 31(11) , 525-30, (2004)]
2003-02-07
[J. Org. Chem. 68(3) , 974-9, (2003)]
Occupational contact dermatitis from trans-methyl-3-(4-methoxyphenyl)glycidate.
1991-10-01
[Contact Dermatitis 25(4) , 262-3, (1991)]
Dermatitis from methyl 2,3 epoxy-3-(4-methoxyphenyl)propionate.
1990-11-01
[Contact Dermatitis 23(5) , 382, (1990)]
Leukocytosis and low serum IgA in workers exposed to the epoxy compound, t-methyl-3-phenylglycidate.
1988-01-01
[Int. Arch. Occup. Environ. Health 60(1) , 7-14, (1988)]